Clear cell carcinoma of the ovary: Potential pathogenic mechanisms (review)

Oncology Reports

Volumn 23, Issue 5, 2010, Pages 1193-1203

  Kajihara, Hirotaka ^a   Yamada, Yoshihiko ^a   Kanayama, Seiji ^a   Furukawa, Naoto ^a   Noguchi, Taketoshi ^a   Haruta, Shoji ^a   Yoshida, Shozo ^a   Sado, Toshiyuki ^a   Oi, Hidekazu ^a   Kobayashi, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Clear cell carcinoma; Detoxification; Epithelial ovarian cancer; Oxidative stress; Pathophysiology

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; CYCLIN E; DIPEPTIDYL PEPTIDASE IV; EPHRIN B1; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GALECTIN 3; GLUCOKINASE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 2; GLUCURONOSYLTRANSFERASE 1A1; GLUTAREDOXIN; GLUTATHIONE PEROXIDASE 3; HEPATOCYTE NUCLEAR FACTOR 1BETA; KIDNEY INJURY MOLECULE 1; LIPOCORTIN 4; MAMMALIAN TARGET OF RAPAMYCIN; MANGANESE SUPEROXIDE DISMUTASE; MATRIX METALLOPROTEINASE; MONOCARBOXYLATE TRANSPORTER 4; MUCIN 1; NICOTINAMIDE METHYLTRANSFERASE; NUCLEOSIDE PHOSPHORYLASE; OCTAMER TRANSCRIPTION FACTOR 4; OSTEOPONTIN; OXIDOREDUCTASE; PLACENTA PROTEIN 5; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; THIOSULFATE SULFURTRANSFERASE; TRANSCRIPTION FACTOR PAX8; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL FUNCTION; CELL METABOLISM; CELL STRESS; CLEAR CELL CARCINOMA; DATA BASE; DETOXIFICATION; DIET; DNA DAMAGE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLYCOGEN SYNTHESIS; HUMAN; LIFESTYLE; MEDLINE; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; OVARY CARCINOMA; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, CLEAR CELL; ANTIOXIDANTS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; OVARIAN NEOPLASMS; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 77950846641     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000750     Document Type: Review

References (106)

1. Roh MH, Kindelberger D and Crum CP: Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Am J Surg Pathol 33: 376-383, 2009.
2. Kurman RJ, Visvanathan K, Roden R, Wu TC and Shih IeM: Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gyneco 198: 351-356, 2008. (Pubitemid 351451941)
3. Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y and Kubo T: Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60: 7052-7056, 2000. (Pubitemid 32059184)
4. Moreno-Bueno G, Gamallo C, Perez-Gallego L, de Mora JC, Suarez A and Palacios J: beta-Catenin expression pattern, betacatenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagn Mol Pathol 10: 116-122, 2001. (Pubitemid 32525880)
5. Auner V, Kriegshäuser G, Tong D, Horvat R, Reinthaller A, Mustea A and Zeillinger R: KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay. BMC Cancer 9: 111, 2009.
6. Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, Høgdall C, Blaakaer J; Ovarian Cancer Association Consortium, Easton DF, Ponder BA, Jacobs IJ, Menon U, Whittemore AS, Krüger-Kjaer S, Pearce CL, Pharoah PD and Gayther SA: Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. Br J Cancer 100: 993-1001, 2009.
7. Kuo KT, Mao TL, Jones S, Veras E, Ayhan A, Wang TL, Glas R, Slamon D, Velculescu VE, Kuman RJ and Shih Ie M: Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am J Pathol 174: 1597-1601, 2009.
8. Kobayashi H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T and Oi H: The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary. Int J Gynecol Cancer 19: 471-479, 2009.
9. Kobayashi H, Sumimoto K, Kitanaka T, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S, Shigetomi H, Haruta S, Tsuji Y, Ueda S and Terao T: Ovarian endometrioma - risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol 138: 187-193, 2008. (Pubitemid 351738251)
10. Yamamoto S, Tsuda H, Takano M, Hase K, Tamai S and Matsubara O: Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway. J Pathol 216: 103-110, 2008.
11. Shan W and Liu J: Epithelial ovarian cancer. Focus on genetics and animal models. Cell Cycle 8: 731-735, 2009.
12. Yoshida S, Furukawa N, Haruta S, Tanase Y, Kanayama S, Noguchi T, Sakata M, Yamada Y, Oi H and Kobayashi H: Theoretical model of treatment strategies for clear cell carcinoma of the ovary: Focus on perspectives. Cancer Treat Rev, Aug 7, 2009 (Epub ahead of print).
13. Kobayashi H, Kajiwara H, Kanayama S, Yamada Y, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T and Oi H: Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review). Oncol Rep 22: 233-240, 2009.
14. Mandai M, Yamaguchi K, Matsumura N, Baba T and Konishi I: Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol 14: 383-391, 2009.
15. Ames BN, Shigenaga MK and Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90: 7915-7922, 1993.
16. Limón-Pacheco J and Gonsebatt ME: The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat Res 674: 137-147, 2009.
17. Storz G and Imlay JA: Oxidative stress. Curr Opin Microbiol 2: 188-194, 1999. (Pubitemid 29176944)
18. Barnouin K, Dubuisson ML, Child ES, Fernandez de Mattos S, Glassford J, Medema RH, Mann DJ and Lam EW: H2O2 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression. J Biol Chem 277: 13761-13770, 2002.
19. Davies KJ: Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 50: 279-289, 2000.
20. Cerutti PA: Oxy-radicals and cancer. Lancet 344: 862-863, 1994.
21. Toyokuni S: Molecular mechanisms of oxidative stress-induced carcinogenesis: from epidemiology to oxygenomics. IUBMB Life 60: 441-447, 2008.
22. Kobayashi H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T and Oi H: The role of iron in the pathogenesis of endometriosis. Gynecol Endocrinol 25: 39-52, 2009.
23. Karihtala P and Soini Y: Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS 115: 81-103, 2007. (Pubitemid 46208084)
24. Qutub AA and Popel AS: Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia. Mol Cell Biol 28: 5106-5119, 2008.
25. Pedersen MØ, Larsen A, Stoltenberg M and Penkowa M: The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem 44: 29-64, 2009.
26. Connor KM, Hempel N, Nelson KK, Dabiri G, Gamarra A, Belarmino J, Van De Water L, Mian BM and Melendez JA: Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells. Cancer Res 67: 10260-10267, 2007. (Pubitemid 350070799)
27. Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, Kaestner KH, Rossi JM, Zaret KS and Duncan SA: Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 34: 292-296, 2003. (Pubitemid 36792861)
28. Lee YH, Sauer B and Gonzalez FJ: Laron dwarfism and noninsulin- dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol 18: 3059-3068, 1998. (Pubitemid 28183474)
29. Qadri I, Iwahashi M, Kullak-Ublick GA and Simon FR: Hepatocyte nuclear factor (HNF) 1 and HNF4 mediate hepatic multidrug resistance protein 2 up-regulation during hepatitis C virus gene expression. Mol Pharmacol 70: 627-636, 2006. (Pubitemid 44092323)
30. Guo H, Wei J, Inoue Y, Gonzalez FJ and Kuo PC: Serine/threonine phosphorylation regulates HNF-4alpha-dependent redox-mediated iNOS expression in hepatocytes. Am J Physiol Cell Physiol 284: C1090-C1099, 2003. (Pubitemid 36336966)
31. Muppala V, Lin CS and Lee YH: The role of HNF-1alpha in controlling hepatic catalase activity. Mol Pharmacol 57: 93-100, 2000. (Pubitemid 30033264)
32. Liu P, Khurana A, Rattan R, He X, Kalloger S, Dowdy S, Gilks B and Shridhar V: Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer. Cancer Res 69: 4843-4850, 2009.
33. Krupczak-Hollis K, Wang X, Kalinichenko VV, Gusarova GA, Wang IC, Dennewitz MB, Yoder HM, Kiyokawa H, Kaestner KH and Costa RH: The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis. Dev Biol 276: 74-88, 2004. (Pubitemid 39452847)
34. Xie S, Wu H, Wang Q, Kunicki J, Thomas RO, Hollingsworth RE, Cogswell J and Dai W: Genotoxic stress-induced activation of Plk3 is partly mediated by Chk2. Cell Cycle 1: 424-429, 2002.
35. Trenz K, Errico A and Costanzo V: Plx1 is required for chromosomal DNA replication under stressful conditions. EMBO J 27: 876-885, 2008. (Pubitemid 351417175)
36. Xie S, Wang Q, Wu H, Cogswell J, Lu L, Jhanwar-Uniyal M and Dai W: Reactive oxygen species-induced phosphorylation of p53 on serine 20 is mediated in part by polo-like kinase-3. J Biol Chem 276: 36194-36199, 2001. (Pubitemid 37384223)
37. Schöler HR: Octamania: the POU factors in murine development. Trends Genet 7: 323-329, 1991.
38. Tantin D, Schild-Poulter C, Wang V, Haché RJ and Sharp PA: The octamer binding transcription factor Oct-1 is a stress sensor. Cancer Res 65: 10750-10758, 2005. (Pubitemid 41713343)
39. Ishii Y, Hansen AJ and Mackenzie PI: Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter. Mol Pharmacol 57: 940-947, 2000. (Pubitemid 30253377)
40. Wu G, Bohn S and Ryffel GU: The HNF1beta transcription factor has several domains involved in nephrogenesis and partially rescues Pax8/lim1-induced kidney malformations. Eur J Biochem 271: 3715-3728, 2004. (Pubitemid 39233614)
41. Tell G, Quadrifoglio F, Tiribelli C and Kelley MR: The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 11: 601-620, 2009.
42. Wentzel P and Eriksson UJ: Genetic influence on dysmorphogenesis in embryos from different rat strains exposed to ethanol in vivo and in vitro. Alcohol Clin Exp Res 32: 874-887, 2008. (Pubitemid 351589400)
43. Vascotto C, Cesaratto L, Zeef LA, Deganuto M, D'Ambrosio C, Scaloni A, Romanello M, Damante G, Taglialatela G, Delneri D, Kelley MR, Mitra S, Quadrifoglio F and Tell G: Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics 9: 1058-1074, 2009.
44. Makino H, Miyamoto Y, Sawai K, Mori K, Mukoyama M, Nakao K, Yoshimasa Y and Suga S: Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 55: 2747-2756, 2006. (Pubitemid 44923673)
45. Yin L, Huang L and Kufe D: MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress. J Biol Chem 279: 45721-45727, 2004. (Pubitemid 39491562)
46. Mazurek N, Sun YJ, Price JE, Ramdas L, Schober W, Nangia- Makker P, Byrd JC, Raz A and Bresalier RS: Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes. Cancer Res 65: 10767-10775, 2005. (Pubitemid 41713345)
47. Fernandes Bertocchi AP, Campanhole G, Wang PH, Gonçalves GM, Damião MJ, Cenedeze MA, Beraldo FC, de Paula Antunes Teixeira V, Dos Reis MA, Mazzali M, Pacheco-Silva A and Câmara NO: A role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury. Transpl Int 21: 999-1007, 2008.
48. Rhodes JM, Campbell BJ and Yu LG: Lectin-epithelial interactions in the human colon. Biochem Soc Trans 36: 1482-1486, 2008.
49. Ozaki N, Matheis KA, Gamber M, Feidl T, Nolte T, Kalkuhl A and Deschl U: Identification of genes involved in gentamicininduced nephrotoxicity in rats - A toxicogenomic investigation. Exp Toxicol Pathol, Aug 5, 2009 (Epub ahead of print).
50. Dieterich C, Puey A, Lin S, Swezey R, Furimsky A, Fairchild D, Mirsalis JC and Ng HH: Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates. Toxicol Sci 107: 258-269, 2009.
51. Ragheb A, Attia A, Eldin WS, Elbarbry F, Gazarin S and Shoker A: The protective effect of thymoquinone, an antioxidant and anti-inflammatory agent, against renal injury: A review. Saudi J Kidney Dis Transpl 20: 741-752, 2009.
52. Nakazato T, Kanuma T, Tamura T, Faried LS, Aoki H and Minegishi T: Sperm protein 17 influences the tissue-specific malignancy of clear cell adenocarcinoma in human epithelial ovarian cancer. Int J Gynecol Cancer 17: 426-432, 2007. (Pubitemid 46426772)
53. Andreucci M, Fuiano G, Presta P, Lucisano G, Leone F, Fuiano L, Bisesti V, Esposito P, Russo D, Memoli B, Faga T and Michael A: Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin. Cell Prolif 42: 554-561, 2009.
54. Zhang H, Kong X, Kang J, Su J, Li Y, Zhong J and Sun L: Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol Sci 110: 376-388, 2009.
55. Mahajan NP, Liu Y, Majumder S, Warren MR, Parker CE, Mohler JL, Earp HS and Whang YE: Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Proc Natl Acad Sci USA 104: 8438-8443, 2007. (Pubitemid 47175506)
56. Del Mare S, Salah Z and Aqeilan RI: WWOX: its genomics, partners, and functions. J Cell Biochem, Aug 25, 2009 (Epub ahead of print).
57. Salnikow K, Su W, Blagosklonny MV and Costa M: Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res 60: 3375-3378, 2000. (Pubitemid 30482149)
58. Wimmer U, Wang Y, Georgiev O and Schaffner W: Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione. Nucleic Acids Res 33: 5715-5727, 2005. (Pubitemid 41742592)
59. Avivi A, Brodsky L, Nevo E and Band MR: Differential expression profiling of the blind subterranean mole rat Spalax ehrenbergi superspecies: bioprospecting for hypoxia tolerance. Physiol Genomics 27: 54-64, 2006. (Pubitemid 44511825)
60. Nin M, Katoh N, Kokura S, Handa O, Yoshikawa T and Kishimoto S: Dichotomous effect of ultraviolet B on the expression of corneodesmosomal enzymes in human epidermal keratinocytes. J Dermatol Sci 54: 17-24, 2009.
61. Dailey G: Beyond insulin replacement: addressing the additional needs of the diabetes patient. Diabetes Obes Metab 10: 83-97, 2008.
62. Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, Backx PH, Tsushima RG, Scholey JW, Khokha R and Penninger JM: Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res 75: 29-39, 2007. (Pubitemid 46873522)
63. Malakauskas SM, Kourany WM, Zhang XY, Lu D, Stevens RD, Koves TR, Hohmeier HE, Muoio DM, Newgard CB and Le TH: Increased insulin sensitivity in mice lacking collectrin, a downstream target of HNF-1alpha. Mol Endocrinol 23: 881-892, 2009.
64. Kumar B, Koul S, Khandrika L, Meacham RB and Koul HK: Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 68: 1777-1785, 2008. (Pubitemid 351416563)
65. Hemmerlein B, Johanns U, Halbfass J, Böttcher T, Heuser M, Radzun HJ and Thelen P: The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide. Int J Oncol 24: 1069-1076, 2004.
66. Zhao W, Zhao T, Chen Y, Ahokas RA and Sun Y: Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol Cell Biochem 317: 43-50, 2008.
67. Moore R, Hawley A, Sigler R, Farris D, Wrobleski S, Ramacciotti E and Myers D: Tissue inhibitor of metalloproteinase- 1 is an early marker of acute endothelial dysfunction in a rodent model of venous oxidative injury. Ann Vasc Surg 23: 498-505, 2009.
68. Kang TH, Bae KH, Yu MJ, Kim WK, Hwang HR, Jung H, Lee PY, Kang S, Yoon TS, Park SG, Ryu SE and Lee SC: Phosphoproteomic analysis of neuronal cell death by glutamateinduced oxidative stress. Proteomics 7: 2624-2635, 2007. (Pubitemid 47253821)
69. Sangwan V, Paliouras GN, Abella JV, Dubé N, Monast A, Tremblay ML and Park M: Regulation of the Met receptortyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase. J Biol Chem 284: 34374-34383, 2008.
70. Chanda D, Li T, Song KH, Kim YH, Sim J, Lee CH, Chiang JY and Choi HS: HGF family negatively regulates hepatic gluconeogenesis via induction of orphan nuclear receptor SHP in primary hepatocytes. J Biol Chem 284: 28510-28521, 2009.
71. Bonomini F, Tengattini S, Fabiano A, Bianchi R and Rezzani R: Atherosclerosis and oxidative stress. Histol Histopathol 23: 381-390, 2008.
72. Urata Y, Ihara Y, Murata H, Goto S, Koji T, Yodoi J, Inoue S and Kondo T: 17Beta-estradiol protects against oxidative stressinduced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J Biol Chem 281: 13092-13102, 2006. (Pubitemid 43855219)
73. Fujii J, Iuchi Y and Okada F: Fundamental roles of reactive oxygen species and protective mechanisms in the female reproductive system. Reprod Biol Endocrinol 3: 43, 2005. (Pubitemid 41522393)
74. Funato Y and Miki H: Nucleoredoxin, a novel thioredoxin family member involved in cell growth and differentiation. Antioxid Redox Signal 9: 1035-1057, 2007. (Pubitemid 47080819)
75. Rodríguez-Ariza A, López-Sánchez LM, González R, Corrales FJ, López P, Bernardos A and Muntané J: Altered protein expression and protein nitration pattern during d-galactosamine-induced cell death in human hepatocytes: a proteomic analysis. Liver Int 25: 1259-1269, 2005. (Pubitemid 41786701)
76. Huls M, Russel FG and Masereeuw R: The role of ATP binding cassette transporters in tissue defense and organ regeneration. J Pharmacol Exp Ther 328: 3-9, 2009.
77. Ghio AJ: Disruption of iron homeostasis and lung disease. Biochim Biophys Acta 1790: 731-739, 2009.
78. Klungland A, Höss M, Gunz D, Constantinou A, Clarkson SG, Doetsch PW, Bolton PH, Wood RD and Lindahl T: Base excision repair of oxidative DNA damage activated by XPG protein. Mol Cell 3: 33-42, 1999. (Pubitemid 29292475)
79. Hallmann A, Milczarek R, Lipinski M, Kossowska E, Spodnik JH, Wozniak M, Wakabayashi T and Klimek J: Fast perinuclear clustering of mitochondria in oxidatively stressed human choriocarcinoma cells. Folia Morphol (Warsz) 63: 407-412, 2004. (Pubitemid 39654619)
80. Cicchillitti L, Penci R, Di Michele M, Filippetti F, Rotilio D, Donati MB, Scambia G and Ferlini C: Proteomic characterization of cytoskeletal and mitochondrial class III beta-tubulin. Mol Cancer Ther 7: 2070-2079, 2008.
81. Wolak T, Kim H, Ren Y, Kim J, Vaziri ND and Nicholas SB: Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int 76: 32-43, 2009.
82. Corley SM, Ladiwala U, Besson A and Yong VW: Astrocytes attenuate oligodendrocyte death in vitro through an alpha(6) integrin-laminin-dependent mechanism. Glia 36: 281-294, 2001. (Pubitemid 34010057)
83. Yeh CH, Chang CK, Cheng MF, Lin HJ and Cheng JT: The antioxidative effect of bone morphogenetic protein-7 against high glucose-induced oxidative stress in mesangial cells. Biochem Biophys Res Commun 382: 292-297, 2009.
84. Wagenaar GT, ter Horst SA, van Gastelen MA, Leijser LM, Mauad T, van der Velden PA, de Heer E, Hiemstra PS, Poorthuis BJ and Walther FJ: Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic Biol Med 36: 782-801, 2004. (Pubitemid 38264421)
85. Saha T, Rih JK and Rosen EM: BRCA1 down-regulates cellular levels of reactive oxygen species. FEBS Lett 583: 1535-1543, 2009.
86. Kato N, Sasou S and Motoyama T: Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol 19: 83-89, 2006. (Pubitemid 43250982)
87. Zaffanello M, Brugnara M, Franchini M and Fanos V: TCF2 gene mutation leads to nephro-urological defects of unequal severity: an open question. Med Sci Monit 14: RA78-RA86, 2008. (Pubitemid 351929700)
88. Kato N and Motoyama T: Hepatocyte nuclear factor-1beta (HNF-1beta) in human urogenital organs: its expression and role in embryogenesis and tumorigenesis. Histol Histopathol 24: 1479-1486, 2009.
89. Li K, Prow T, Lemon SM and Beard MR: Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells. Hepatology 35: 1237-1246, 2002. (Pubitemid 34454021)
90. Yueh MF and Tukey RH: Nrf2-Keap1 signaling pathway regulates human UGT1A1 expression in vitro and in transgenic UGT1 mice. J Biol Chem 282: 8749-8758, 2007. (Pubitemid 47093470)
91. Arystarkhova E, Donnet C, Muñoz-Matta A, Specht SC and Sweadner KJ: Multiplicity of expression of FXYD proteins in mammalian cells: dynamic exchange of phospholemman and gamma-subunit in response to stress. Am J Physiol Cell Physiol 292: C1179-C1191, 2007. (Pubitemid 46442642)
92. Pawlak K, Zolbach K, Borawski J, Mysliwiec M, Kovalchuk O, Chyczewski L and Pawlak D: Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients. Thromb Res 123: 166-170, 2008.
93. Hattori K, Naguro I, Runchel C and Ichijo H: The roles of ASK family proteins in stress responses and diseases. Cell Commun Signal 7: 9, 2009.
94. Hu ML and Tappel AL: Glutathione and antioxidants protect microsomes against lipid peroxidation and enzyme inactivation. Lipids 27: 42-45, 1992.
95. Wu L, Nicholson W, Knobel SM, Steffner RJ, May JM, Piston DW and Powers AC: Oxidative stress is a mediator of glucose toxicity in insulin-secreting pancreatic islet cell lines. J Biol Chem 279: 12126-12134, 2004. (Pubitemid 38445777)
96. Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, Sharma A and Weir GC: Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. Biol Chem 276: 31099-31104, 2001. (Pubitemid 37384975)
97. Farrelly AM, Wobser H, Bonner C, Anguissola S, Rehm M, Concannon CG, Prehn JH and Byrne MM: Early loss of mammalian target of rapamycin complex 1 (mTORC1) signalling and reduction in cell size during dominant-negative suppression of hepatic nuclear factor 1-alpha (HNF1A) function in INS-1 insulinoma cells. Diabetologia 52: 136-144, 2009.
98. Kohchi C, Inagawa H, Nishizawa T and Soma G: ROS and innate immunity. Anticancer Res 29: 817-821, 2009.
99. Kabat GC and Rohan TE: Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis. Cancer Causes Control 18: 1047-1053, 2007.
100. Fukuda A, Osawa T, Oda H, Toyokuni S, Satoh K and Uchida K: Oxidative stress response in iron-induced renal carcinogenesis: acute nephrotoxicity mediates the enhanced expression of glutathione S-transferase Yp isozyme. Arch Biochem Biophys 329: 39-46, 1996. (Pubitemid 26143395)
101. Toyokuni S: Mechanisms of asbestos-induced carcinogenesis. Nagoya J Med Sci 71: 1-10, 2009.
102. Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K and Fujii S: Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res 14: 32-40, 2008. (Pubitemid 351377975)
103. Sandhu JK, Haggani AS and Birnboim HC: Effect of dietary E on spontaneous or nitric oxide donor-induced mutations in a mouse tumor model. J Natl Cancer Inst 92: 1429-1433, 2000.
104. Garcia-Alonso FJ, Guidarelli A and Periago MJ: Phenolic-rich juice prevents DNA single-strand breakage and cytotoxicity caused by tert-butylhydroperoxide in U937 cells: the role of iron chelation. J Nutr Biochem 18: 457-466, 2007. (Pubitemid 46881227)
105. Samuni AM, Krishna MC, DeGraff W, Russo A, Planalp RP, Brechbiel MW and Mitchell JB: Mechanisms underlying the cytotoxic effects of Tachpyr - a novel metal chelator. Biochim Biophys Acta 1571: 211-218, 2002. (Pubitemid 34686923)
106. Abalea V, Cillard J, Dubos MP, Sergent O, Cillard P and Morel I: Repair of iron-induced DNA oxidation by the flavonoid myricetin in primary rat hepatocyte cultures. Free Radic Biol Med 26: 1457-1466, 1999. (Pubitemid 29302277)